Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

放射線によって引き起こされる癌のリスク

B E Lambert

    Lancet (London, England)
    |May 7, 1988
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Comments on "Impact of tritium around EDF nuclear power plants".

    Journal of radiological protection : official journal of the Society for Radiological Protection·2009
    Same author

    Comments on "Are the risks from tritium exposures being underestimated?".

    Journal of radiological protection : official journal of the Society for Radiological Protection·2009
    Same author

    Systematic review of experimental studies on the relative biological effectiveness of tritium.

    Radiation and environmental biophysics·2007
    Same author

    Uncertainties in dose coefficients for intakes of tritiated water and organically bound forms of tritium by members of the public.

    Radiation protection dosimetry·2002
    Same author

    Chromosomal instability in haemopoietic cells of the foetus, mother and offspring after in utero irradiation of the CBA/Ca mouse.

    International journal of radiation biology·2001
    Same author

    Standards for environmental, non-threshold, carcinogens: a comparison of the approaches used for radiation and for chemicals.

    The Annals of occupational hygiene·1998
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る